Omnicell Inc (NASDAQ: OMCL) is a healthcare technology company that provides automated pharmacy and medication management solutions to hospitals, health systems, and other healthcare facilities. The company generates revenue through a combination of product sales, software subscriptions, and services tied to its automated dispensing cabinets, central pharmacy automation systems, and related software platforms. The filing excerpt provided does not supply sufficient detail to characterize segment revenue percentages, customer counts, geographic mix, competitive positioning, or leadership history from this specific 10-K filed 2026-02-26 (accession 000092632626000006). Based solely on the available excerpt, Omnicell is headquartered in the United States, incorporated as a Delaware entity, and lists its securities on a national exchange under the ticker OMCL. No further financial specifics, competitor names, or business-quality conclusions are supported by the excerpts provided.

Revenue model

The filing excerpts do not provide sufficient detail to characterize the revenue model with specific figures or segment breakdowns from this filing.

Products and services

The filing excerpts do not provide sufficient product or service detail to enumerate specific offerings beyond what is publicly known outside the supplied text.

Customers and end markets

The filing excerpts do not identify specific customer segments, customer counts, or end market details.

Value-chain role

The filing excerpts do not provide sufficient detail to define Omnicell's value-chain role from the supplied text alone.

Geographic exposure

The filing excerpts do not provide geographic revenue breakdowns or country-level detail.

Source: SEC 10-K, filed 2026-02-26

Industry: Electronic Computers Peers: Abbott Laboratories Axonics, Inc. QuidelOrtho Corp Envista Holdings Corp Inari Medical, Inc. Inspire Medical Systems Inc Integra Lifesciences Holdings Corp iRhythm Holdings, Inc Penumbra Inc